Liposomal anticancer compositions
US11033520B2 · kind B2 · utility
1Cited by
9References
32Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 1, 2017 |
| Grant date | Jun 15, 2021 |
| Priority date | — |
| Expiry date | Sep 4, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein includes methods and compositions for the treatment of cancer. Described herein are liposome encapsulated chemotherapeutic agents, encompassing a weakly basic anticancer compound and an acid or salt thereof, wherein the acid is oxalic acid or tartaric acid and methods for preparing and utilizing the same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.